Opening the book…
This work can take years. The time, cost, and chance of success depend on the product, the disease, and the development plan. A team may stop development when the risks are too high, the benefits are too small, or the product cannot be made reliably.
The drug substance is the active material. It is often called the active pharmaceutical ingredient (API). The drug product is the finished form a patient receives, such as a tablet or an injectable solution. A therapeutic biological product can be a medicine such as a therapeutic protein or antibody. The term biopharmaceutical often refers to a medicine made using biological systems or biotechnology.

This page titled 12.1: From Discovery to the Market was last modified on Mon, 09 Nov 2026 04:52:41 GMT and is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by Emalee MacKenzie.
The book could not be loaded just now.